Is Y-90 resin microspheres better or worse than Sorafenib for treating liver cancer?

Lancet Oncology published results from a phase 3 study comparing radiation therapy with yttrium(Y)-90 resin microspheres to standard therapy (sorafenib) in patient with liver cancer. The study observed that efficacy was the same for both treatments.
RareDr